Atlas FDA

C2 A-TAPER ACETABULAR SYSTEM

FDA premarket approval P050009 · decided 2005-12-16

Approval details

PMA number
P050009
Trade name
C2 A-TAPER ACETABULAR SYSTEM
Generic name
Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented
Applicant
Biomet, Inc.
Date received
2005-03-14
Decision date
2005-12-16
Days to decision
277 days
Decision code
APWD
Product code
MRA
Advisory committee
Orthopedic
Expedited review
No
Location
Warsaw, IN
Statement
APPROVAL FOR THE C2A-TAPER ACETABULAR SYSTEM. THE DEVICE IS INDICATED FOR USE IN PRIMARY TOTAL HIP ARTHROPLASTY IN SKELETALLY MATURE PATIENTS WITH NON-INFLAMMATORY DEGENERATIVE JOINT DISEASE SUCH AS OSTEOARTHRITIS, AVASCULAR NECROSIS, CONGENITAL HIP DYSPLASIA, AND POST-TRAUMATIC ARTHRITIS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
OSSTM Orthopedic Salvage System (K253434)Biomet, Inc.2026-07-01
Taperloc® Complete Hip Stem (K251270)Biomet, Inc.2026-05-19
Biomet Kirschner Wires (K-Wires) (K241014)Biomet, Inc.2024-05-22
StageOne™ Select Hip Cement Spacer Molds (K222760)Biomet, Inc.2022-12-28
StageOne™ Shoulder Cement Spacer Molds (K221968)Biomet, Inc.2022-09-15
StageOne Knee Cement Spacer Molds (K213287)Biomet, Inc.2022-09-02
Biomet Answer/Impact/Integral Distal Centralizer/Centering Sleeve (K212431)Biomet, Inc.2022-02-07
Comprehensive Humeral Fracture Positioning Sleeves (K212435)Biomet, Inc.2021-12-10